Pax Financial Group, LLC Edwards Lifesciences Corp Transaction History

Pax Financial Group, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	BUY	$69.28 - $93.38 $502,210 - $676,911	7,249 New	7,249 $502,000
Q2 2022 Aug 09, 2022	SELL	$86.5 - $128.27 $358,283 - $531,294	-4,142 Closed	0 $0
Q1 2022 May 10, 2022	BUY	$101.96 - $128.34 $111,544 - $140,403	1,094 Added 35.89%	4,142 $488,000
Q4 2021 Feb 07, 2022	BUY	$106.37 - $130.68 $324,215 - $398,312	3,048 New	3,048 $395,000
Q2 2020 Jul 31, 2020	SELL	$57.54 - $76.95 $56,849 - $76,026	-988 Closed	0 $0
Q1 2020 Apr 28, 2020	BUY	$52.41 - $81.0 $51,781 - $80,028	988 New	988 $221,000

1,417

469M

2.44M

2.65M

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $40.5B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

Get notified when there are updates to the investment portfolio of Pax Financial Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Pax Financial Group, LLC with notifications on news.